That was just the most recent hit from the NNVC "play list":
"My guess - we see Phase I Clinical trials for the anti-Shingles drug begin in Australia no earlier than April-May, and possibly not until Summer. If the Phase I goes smoothly, they should be able to get Phase II rolling during the Summer or Early Fall - assuming that they plan to do that in Australia as well and have their clinical 'ducks' all in a row. "
"I want to see 'something' go into TOX testing by sometime this Summer. My confidence will remain high until at least then,... afterwards I'll be wanting a few questions answered by the company as to what might be causing a delay. "
"I think a lot of pieces are moving - just out of sight of us and of the market. It would not shock me in the least to have some very positive bits of news start to come out over the next few weeks. In fact - I am starting to feel anticipatory for the first time this year."
"I would view that as a definite bit of positive news - if we were to get it before [insert date] starts."
"I'm guessing that we'll be hearing some news about the tox work being done soon, and hopefully that will let us hold back up over $1 for a while."
Market Data 
Markets 
AI
